Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653

Watchlist Manager
Yantai Zhenghai Bio-Tech Co Ltd Logo
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Watchlist
Price: 21.23 CNY -5.64% Market Closed
Market Cap: 3.8B CNY
Have any thoughts about
Yantai Zhenghai Bio-Tech Co Ltd?
Write Note

Relative Value

The Relative Value of one Yantai Zhenghai Bio-Tech Co Ltd stock under the Base Case scenario is 33.14 CNY. Compared to the current market price of 21.23 CNY, Yantai Zhenghai Bio-Tech Co Ltd is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
33.14 CNY
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
45
Median 3Y
15.6
Median 5Y
15.9
Industry
7.7
Forward
9.5
vs History
84
vs Industry
7
Median 3Y
35.9
Median 5Y
38.9
Industry
22.7
Forward
21.2
vs History
90
vs Industry
7
Median 3Y
37.5
Median 5Y
38.8
Industry
21.6
vs History
93
vs Industry
6
Median 3Y
45.6
Median 5Y
58.9
Industry
25.2
vs History
85
vs Industry
21
Median 3Y
7.7
Median 5Y
7.6
Industry
2.5
vs History
84
vs Industry
41
Median 3Y
14
Median 5Y
15.1
Industry
7.7
Forward
8.1
vs History
84
vs Industry
38
Median 3Y
16
Median 5Y
16.3
Industry
9
vs History
84
vs Industry
7
Median 3Y
31.3
Median 5Y
34.4
Industry
4.2
Forward
16.3
vs History
84
vs Industry
6
Median 3Y
31.3
Median 5Y
34.4
Industry
4.1
Forward
10
vs History
88
vs Industry
8
Median 3Y
34.1
Median 5Y
35.6
Industry
5.7
vs History
93
vs Industry
6
Median 3Y
42.1
Median 5Y
54.4
Industry
3.6
vs History
80
vs Industry
23
Median 3Y
19.8
Median 5Y
17.3
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Yantai Zhenghai Bio-Tech Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
3.8B CNY 10 22.8 18.7 18.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
CN
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Average P/E: 177.4
22.8
25%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Average EV/EBITDA: 17.4
18.7
40%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Average EV/EBIT: 22
18.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top